The World Health Organization (WHO) has sought to reassure the public about the risk of bird flu following the death of a patient in Louisiana, marking the first fatality from H5N1 in the United States. The patient, aged over 65 with underlying health conditions, contracted the virus in December after exposure to backyard chickens and wild birds, according to Louisiana health officials.
Speaking at a press briefing in Geneva on Tuesday, WHO spokesperson Margaret Harris said, “We are concerned, of course, but we look at the risk to the general population, and it still remains low.”
Harris also acknowledged the extensive surveillance efforts in the U.S. “They are doing a lot of monitoring. That’s why we’re hearing about it,” she added when asked about the adequacy of tracking measures in the country.
According to the U.S. Centers for Disease Control and Prevention (CDC), nearly 70 individuals, primarily farmworkers, have been infected with H5N1 bird flu since April. The virus has been circulating among poultry flocks and, in some instances, dairy herds. Like the WHO, U.S. federal and state officials maintain that the risk to the general public remains low.
Experts have been closely monitoring H5N1 for signs of mutation or increased transmissibility in humans. While the virus primarily affects birds, rare cases of human infection typically occur through direct exposure to infected animals.
The CDC continues to encourage poultry workers and others in high-risk environments to exercise caution and follow biosecurity measures to prevent further infections. Public health officials are also urging individuals to report unusual bird die-offs and maintain vigilance during outbreaks.
Despite the isolated U.S. case, the WHO and CDC stress that the general public remains at minimal risk, with ongoing surveillance efforts designed to detect and address potential threats promptly.
Read next
13:53
Local hospitals are overrun by a mysterious illness. The Sudanese town of al-Hilalya has seen at least 73 deaths according to local doctors. It comes as violence and displacement in eastern El Gezira state continue to intensify. It has been under siege by the paramilitary Rapid Support Forces (RSF).
22:46
AstraZeneca’s new weight-loss pill, AZD5004, shows promise in early trials with tolerable side effects, advancing to Phase II studies focused on reducing obesity.
13:36
An analysis of U.S. health claims reveals that while GLP-1 drugs like Wegovy may aid weight loss, they significantly increase medical costs—rising to $18,507 annually—without reducing obesity-related health events, raising concerns for insurers and employers.
10:08
The CDC confirms bird flu in two Washington poultry workers and ruled out infections in Missouri healthcare staff.
14:48
UK government has confirmed that disposable vapes will be banned from sale starting June 2025
What is your opinion on this topic?
Leave the first comment